drugset
drugset / Trial / NCT04861051

Understanding Ketamine's Dissociative Effects (KD Study)

NCT04861051 ↗

Phase 1 Recruiting 20 enrolled Stanford University
NaSingle-groupOpen-labelBasic science

Summary

The purpose of this study is to understand how ketamine brings about dissociative symptoms.

Timeline

Start
2021-07-26
Primary completion
2028-08-01
Completion
2028-08-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Ketamine Small molecule 0.5 mg/kg —

Indications

epilepsy